Dr Reddys Laboratories Stock Performance
| RDY Stock | USD 14.60 0.19 1.32% |
Dr Reddys has a performance score of 4 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.58, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dr Reddys' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Reddys is expected to be smaller as well. Dr Reddys Laboratories at this time owns a risk of 1.43%. Please confirm Dr Reddys Laboratories value at risk, and the relationship between the standard deviation and kurtosis , to decide if Dr Reddys Laboratories will be following its current price history.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.96) | Five Day Return (2.17) | Year To Date Return (8.04) | Ten Year Return 16.68 | All Time Return 1.3 K |
Forward Dividend Yield 0.0065 | Payout Ratio | Last Split Factor 5:1 | Forward Dividend Rate 0.09 | Dividend Date 2024-08-12 |
1 | Clark Asset Management LLC Invests 301,000 in Abbott Laboratories | 07/03/2025 |
2 | Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2025 Financial Results | 07/08/2025 |
3 | Blood Glucose Monitoring Market Generated Opportunities, Future Scope by 2032 Medtronic, ACON Laboratories, Inc. | 07/11/2025 |
4 | Kornitzer Capital Management Inc. KS Has 51.53 Million Holdings in Abbott Laboratories | 07/15/2025 |
5 | HRL Laboratories Launches Open-Source Solution for Solid-State Spin-Qubits | 07/16/2025 |
6 | Why Abbott Laboratories Shares Are Plunging Today | 07/17/2025 |
7 | Forte Capital LLC ADV Sells 1,804 Shares of Abbott Laboratories | 07/18/2025 |
8 | Blue Bell Private Wealth Management LLC Increases Stock Holdings in Abbott Laboratories | 07/21/2025 |
| Begin Period Cash Flow | 7.1 B | |
| Total Cashflows From Investing Activities | -58.1 B |
Dr Reddys Relative Risk vs. Return Landscape
If you would invest 1,400 in Dr Reddys Laboratories on April 24, 2025 and sell it today you would earn a total of 60.00 from holding Dr Reddys Laboratories or generate 4.29% return on investment over 90 days. Dr Reddys Laboratories is generating 0.0777% of daily returns assuming volatility of 1.431% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than RDY, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Dr Reddys Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Reddys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dr Reddys Laboratories, and traders can use it to determine the average amount a Dr Reddys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0543
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RDY | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Dr Reddys is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Reddys by adding it to a well-diversified portfolio.
Dr Reddys Fundamentals Growth
RDY Stock prices reflect investors' perceptions of the future prospects and financial health of Dr Reddys, and Dr Reddys fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RDY Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 11.85 B | ||||
| Shares Outstanding | 832.37 M | ||||
| Price To Earning | 31.58 X | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 325.54 B | ||||
| Gross Profit | 190.43 B | ||||
| EBITDA | 96.67 B | ||||
| Net Income | 57.24 B | ||||
| Cash And Equivalents | 2.51 B | ||||
| Cash Per Share | 208.58 X | ||||
| Total Debt | 46.77 B | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 1.98 X | ||||
| Book Value Per Share | 400.70 X | ||||
| Cash Flow From Operations | 46.43 B | ||||
| Earnings Per Share | 0.79 X | ||||
| Market Capitalization | 11.99 B | ||||
| Total Asset | 492.99 B | ||||
| Retained Earnings | 315.79 B | ||||
| Working Capital | 119.72 B | ||||
| Current Asset | 1.81 B | ||||
| Current Liabilities | 976 M | ||||
About Dr Reddys Performance
Evaluating Dr Reddys' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Dr Reddys has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dr Reddys has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 192.04 | 167.21 | |
| Return On Tangible Assets | 0.15 | 0.08 | |
| Return On Capital Employed | 0.20 | 0.11 | |
| Return On Assets | 0.11 | 0.07 | |
| Return On Equity | 0.17 | 0.11 |
Things to note about Dr Reddys Laboratories performance evaluation
Checking the ongoing alerts about Dr Reddys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dr Reddys Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Latest headline from thelincolnianonline.com: Blue Bell Private Wealth Management LLC Increases Stock Holdings in Abbott Laboratories |
- Analyzing Dr Reddys' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dr Reddys' stock is overvalued or undervalued compared to its peers.
- Examining Dr Reddys' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dr Reddys' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dr Reddys' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dr Reddys' stock. These opinions can provide insight into Dr Reddys' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.